S
4.70
0.12 (2.62%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Sana Biotechnology, Inc. | 看跌 | 混合的 |
AIStockmoo 评分
0.2
| 分析师共识 | 2.0 |
| 内部交易活动 | 0.0 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.20 |
|
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 8.46% |
| 机构持股比例 | 89.37% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Integral Health Asset Management, Llc | 30 Sep 2025 | 2,000,000 |
| Crestline Management, Lp | 30 Sep 2025 | 1,820,937 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 9.00 (HC Wainwright & Co., 91.49%) | 购买 |
| 中 | 7.50 (59.57%) | |
| 低 | 6.00 (Wedbush, 27.66%) | 购买 |
| 平均值 | 7.50 (59.57%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 4.36 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B of A Securities | 06 Jan 2026 | 7.00 (48.94%) | 购买 | 4.36 |
| HC Wainwright & Co. | 07 Nov 2025 | 9.00 (91.49%) | 购买 | 4.09 |
| Wedbush | 07 Nov 2025 | 6.00 (27.66%) | 购买 | 4.09 |
| Citizens | 30 Oct 2025 | 8.00 (70.21%) | 购买 | 4.90 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BISHOP HANS EDGAR | 4.06 | - | 6,157 | 24,997 |
| WYRICK SUSAN D. | - | 4.06 | -2,407 | -9,772 |
| 累积净数量 | 3,750 | |||
| 累积净值 ($) | 15,225 | |||
| 累积平均购买 ($) | 4.06 | |||
| 累积平均卖出 ($) | 4.06 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| WYRICK SUSAN D. | 职员 | 05 Jan 2026 | 处理 (-) | 2,407 | 4.06 | 9,772 |
| BISHOP HANS EDGAR | 董事 | 05 Jan 2026 | 获得 (+) | 6,157 | 4.06 | 24,997 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合